Get the Stockscreener App
11.99
0.84%
0.10
After Hours:
12.10
0.11
+0.92%
Benitec Biopharma Inc stock is traded at $11.99, with a volume of 185.40K.
It is up +0.84% in the last 24 hours and down -11.71% over the past month.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
See More
Previous Close:
$11.89
Open:
$11.83
24h Volume:
185.40K
Relative Volume:
0.86
Market Cap:
$406.01M
Revenue:
$59,000
Net Income/Loss:
$-21.81M
P/E Ratio:
-1.0948
EPS:
-10.9518
Net Cash Flow:
$-18.07M
1W Performance:
-13.93%
1M Performance:
-11.71%
6M Performance:
-8.96%
1Y Performance:
+4.35%
1-Day Range:
$11.21
$12.05
1-Week Range:
$11.21
$14.39
52-Week Range:
$9.70
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
Name
Benitec Biopharma Inc
Sector
Industry
Phone
(510) 780-0819
Address
3940 TRUST WAY, HAYWARD, CA
Compare BNTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
11.99 | 402.62M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Initiated | TD Cowen | Buy |
| Dec-16-24 | Initiated | H.C. Wainwright | Buy |
| Dec-13-24 | Initiated | Robert W. Baird | Outperform |
| Oct-16-24 | Initiated | Oppenheimer | Outperform |
| Sep-12-24 | Initiated | Guggenheim | Buy |
| Jul-22-24 | Initiated | Leerink Partners | Outperform |
| Jun-13-24 | Initiated | Piper Sandler | Overweight |
| Oct-05-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-20-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-26-16 | Downgrade | Maxim Group | Buy → Hold |
| Dec-31-15 | Reiterated | Maxim Group | Buy |
| Sep-16-15 | Reiterated | Maxim Group | Buy |
View All
Benitec Biopharma Inc Stock (BNTC) Latest News
Suvretta Capital Management, LLC Acquires Additional Shares in Benitec Biopharma Inc - GuruFocus
Discipline and Rules-Based Execution in BNTC Response - Stock Traders Daily
Tahmar Enterprises Limited (516032) Announces Strategic ShiftReal-Time Stock Alerts & Free Stock Trading Workshops - earlytimes.in
Why Benitec Biopharma Inc. stock could be next big winnerInsider Trading Activity & Free Explosive Portfolio Gains - bollywoodhelpline.com
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 16,836 Shares - Defense World
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 77,387 Shares of Stock - Defense World
Benitec Biopharma (NASDAQ:BNTC) Director Purchases $220,551.60 in Stock - MarketBeat
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m By Investing.com - Investing.com Nigeria
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m - Investing.com India
Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect? - Eastern Progress
Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Purchases 50,000 Shares of Stock - MarketBeat
Wall Street analysts predict an 87.48% upside in Benitec Biopharma (BNTC): Here's what you should know - MSN
(BNTC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Purchases 10,215 Shares of Stock - Defense World
Benitec Biopharma: Suvretta capital buys BNTC shares worth $538,972 By Investing.com - Investing.com Australia
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Acquires 16,384 Shares - MarketBeat
Suvretta Capital Management, L Acquires 10,215 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock - MarketBeat
Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Acquires 19,542 Shares of Stock - MarketBeat
Benitec Biopharma: Suvretta capital buys BNTC shares worth $538,972 - Investing.com
Why Benitec Biopharma Inc. stock attracts global investorsQuarterly Market Review & Community Verified Trade Alerts - Улправда
Can Benitec Biopharma Inc. stock double in next 5 yearsBreakout Watch & High Accuracy Buy Signal Tips - Улправда
Benitec Biopharma Earnings Notes - Trefis
Can Benitec Biopharma Inc. stock outperform in 2025 bull market - Улправда
Benitec Biopharma Concludes 2025 Annual Stockholders Meeting - MSN
Is Benitec Biopharma Inc. stock a buy on dips2025 Price Momentum & Daily Profit Maximizing Tips - DonanımHaber
Will Benitec Biopharma Inc. stock attract more institutional investorsWeekly Investment Report & Smart Investment Allocation Insights - DonanımHaber
Entry Recap: Can Benitec Biopharma Inc. stock outperform in 2025 bull marketLong Setup & Daily Chart Pattern Signals - Улправда
Technical Charts Suggest Momentum Shift in Suraj Estate Developers LimitedPrice Action Analysis & Small Investment Growth Tips - earlytimes.in
Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Will Benitec Biopharma Inc stock pay special dividendsJuly 2025 Gainers & AI Driven Stock Movement Reports - moha.gov.vn
Janus Henderson Group PLC's Strategic Acquisition in Benitec Bio - GuruFocus
Aug Setups: Is Benitec Biopharma Inc stock resilient to inflationQuarterly Portfolio Summary & High Return Stock Watch Alerts - moha.gov.vn
Benitec Biopharma prices $100M stock offering - MSN
Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's What You Should Know - Yahoo Finance
Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC) - Yahoo Finance
Benitec Biopharma shareholders approve all proposals at annual meeting By Investing.com - Investing.com Australia
Benitec Biopharma shareholders approve all proposals at annual meeting - Investing.com
Price-Driven Insight from (BNTC) for Rule-Based Strategy - Stock Traders Daily
Can Benitec Biopharma Inc. stock continue upward trendJuly 2025 Momentum & AI Enhanced Execution Alerts - Newser
Benitec Biopharma Inc Stock (BNTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):